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A B S T R A C T
We present a case of a 51-year-old male with acute anterior myocardial infarction, 
who was transferred to our hospital under mechanical ventilation, after resuscita-
tion due to cardiopulmonary arrest. The patient underwent urgent coronary angiog-
raphy, which showed total thrombotic occlusion of the proximal segment of the left 
anterior descending (LAD) coronary artery disease. During primary percutaneous 
coronary intervention (PPCI), thrombosis extended into the left main coronary artery 
(LMCA), the LAD and the left circumflex artery (LCx) coronary arteries, causing 
severe hemodynamic compromise. This devastating complication was successfully 
managed with intracoronary administration of antithrombotic and antiplatelet drugs, 
as well as thrombus aspiration. We herein discuss the possible mechanisms of this 
complication and highlight its prevention and treatment.
I N T R O D U C T I O N
Primary percutaneous coronary intervention (PPCI) improves outcomes in patients 
with acute ST elevation myocardial infarction (STEMI) in comparison to thrombolysis.1 
PPCI can be easily performed in intubated patients with hemodynamic stability and 
should be preferred over thrombolysis, especially when cardiopulmonary resuscitation 
has been performed.2 In this situation, thrombolysis may cause severe hemorrhage due 
to rib fracture or other injury caused by cardiac arrest and subsequent resuscitation. 
We describe a case of a middle-aged male with aborted sudden cardiac death due to 
acute anterior myocardial infarction, who manifested a secondary potentially lethal 
complication during PPCI. 
C A S E  P R E S E N T A T I O N
A 51-year-old male, smoker, without medical history of cardiovascular disease, 
complained of progressive chest discomfort and dizziness. In a short period of time, 
cardiopulmonary arrest occurred. The patient underwent intubation, chest compres-
sions and repetitive defibrillation therapies for ventricular fibrillation by paramedical 
personnel during his transfer to our hospital. In the emergency department, the electro-
cardiogram revealed acute anterior myocardial infarction. Blood pressure was 110/70 
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mmHg. Pupillary light reflex was normal. No signs of rib frac-
ture or major trauma were present on physical examination.
The patient was directly transferred to the catheterization 
laboratory, after intravenous administration of heparin (5000 
IU). Coronary angiography demonstrated a total thrombotic 
occlusion of the proximal segment of the left anterior descend-
ing (LAD) coronary artery and PPCI was performed. After 
predilatation of the total occlusion with a balloon (Sprinter 
2.5x15 mm, inflation at 12 Atm), TIMI-III flow was restored 
within the LAD artery. A bare metal stent (BMS Integrity, 
3.0 x 22 mm) was placed in the culprit lesion. Before stent 
deployment, thrombus formation was noted in the left main 
coronary artery (LMCA), proximal LAD and proximal left 
circumflex (LCx) coronary artery segments. Despite stent 
deployment (at 16 Atm), thrombus formation progressed 
with subsequent flow regression (TIMI-I) in the left coronary 
arteries and cardiogenic shock occurred (bradycardia, severe 
FIgURE 1. A: Total thrombotic occlu-
sion of LAD. Guidewire in distal LAD. 
B: TIMI-III flow in LAD after balloon 
predilatation. C: Stent placement at the 
culprit lesion. Thrombus formation in 
LMCA/LAD/LCx. D: Stent deployment. 
E: TIMI-III restoration in left coronary 
artery after intracoronary drug admin-
istration and thrombus aspiration. LAD 
= left anterior descending; LCx = left 







hypotension). Intracoronary extra loading dose of 5000 IU of 
heparin as well as intracoronary loading dose of abciximab 
were administered directly, followed by thrombus aspiration 
from the LMCA and proximal LAD (E-max catheter). As a 
consequence, hemodynamic stability was restored and repeat 
angiography revealed restoration of TIMI-III flow. Residual 
thrombus in the proximal LAD segment was detected and was 
treated with balloon angioplasty (balloon Sprinter 3.0x15 mm, 
inflation at 12 Atm). 
The final angiographic result was optimal (Figure 1, 
A-E). The patient remained hemodynamically stable and was 
extubated 5 days later, with no neurologic defects. Echocar-
diogram revealed depressed left ventricular systolic function 
(ejection fraction=35-40%) due to hypokinetic anteroseptal 
and akinetic apical wall. The patient was discharged home a 
few days later, with no arrhythmic events and no symptoms 
or signs of heart failure. 
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D I S C U S S I O N
Acute thrombosis is a rare but well-described complica-
tion of primary percutaneous coronary intervention (PPCI), 
especially in the form of acute stent thrombosis.3 This com-
plication is more often in patients with STEMI who undergo 
PPCI. During or right after PPCI, the activated endogenous 
thrombotic mechanism may predominate over antithrombotic 
power of antiplatelet and heparin loading doses. It is well 
known that 600 mg loading dose of clopidogrel achieves its 
full platelet-inhibitory effect within 2 hours.4 Ticagrelor and 
prasugrel may shorten this latent period. Factors like vomiting 
or opioid administration may by responsible for reduced or 
delayed drug absorption after p.o. taking.5,6 Thrombus embo-
lization is another mechanism of occlusion of distal parts or 
branches of the recanalized artery. New thrombus formation 
proximal to the culprit lesion is quite rare and potentially lethal 
complication during PCI.7 
In our patient, the extensive thrombus formation that tran-
siently occluded the left coronary arteries can be partially ex-
plained by the absence of antiplatelet loading dose (intubated 
patient). Intravenous glycoprotein IIb-IIIa inhibitor was not 
administered before the occurrence of thrombus formation, 
due to the risk of traumatic bleeding (resuscitated patient). 
Nevertheless, the subsequent 72-hour administration of glyco-
protein IIb-IIIa inhibitor, in combination with low-molecular 
weight heparin, did not cause any hemorrhagic complication. 
In general, thrombolytic therapy could be preferred over 
extra loading dose of heparin and/or loading dose of abcixmab 
in cases of acute intracoronary thrombosis, depending on the 
extent of thrombus formation and its hemodynamic conse-
quences.8,9 Balloon angioplasty in the thrombotic segment 
of the coronary artery may also be preferred over thrombus 
aspiration, in order to restore TIMI-III flow. The first-line 
drug or mechanical therapy depends mainly on the location 
and extent of thrombus formation. 
In conclusion, in cases of increased risk of acute coronary 
thrombosis during PCI, intravenous administration of glyco-
protein IIb-IIIa inhibitors should be considered. Whenever 
acute thrombosis occurs, aggressive drug therapy with intrave-
nous antithrombotic, antiplatelet or even thrombolytic agents 
and mechanical therapy (balloon angioplasty and/or thrombus 
aspiration) should be performed. 
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